Training Effectiveness Using Complementary Video Game for Rehabilitation in PET / MAH Patients: Randomized Trial

Not Applicable

Recruiting

• Conditions: Carrier of human T-lymphotropic virus type- 1 [HTLV-1] infection; Z22.6

• Registration Number: RBR-8sdrvb
• Lead Sponsor: úcleo de Medicina Tropical

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-06
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Have the confirmed diagnosis of PET / MAH, by an infectologist; refer to mild pain or acute second visual analogue scale (VAS); gait alteration (claudication, use of orthoses as a cane or crutch) and age range between 30 and 60 years.

Exclusion Criteria

Have less than 6 months of PET / MAH diagnosis; have any other neurological diagnosis; use wheelchair; being physio-therapeutic treatment concomitantly to the period of the research; does not meet the inclusion criteria.

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary end point is to compare whether virtual reality associated with conventional physical therapy treatment provided a greater effect than conventional treatment associated with placebo, in the balance of these patients with pet / mah, compared between the moments before and after application of the protocols. As an evaluation method, the force platform will be used, an instrument that measures the center of pressure, and from the collected data, it is possible to verify the displacement area, velocity and amplitude, for example. In addition to the platform, a miniBESTest clinical assessment scale will also be used, which assesses balance through predetermined tasks and scores them between 0 and 2, with a total of 14 questions, reaching 28 points.

Secondary Outcome Measures

Name	Time	Method
The secondary outcome aims to verify whether the virtual reality associated with conventional physical therapy treatment provided a superior effect to conventional treatment associated with placebo, in the quality of life and pain of these patients with pet / mah, compared between the pre and post application of the protocols. For this evaluation, a clinical scale called short-form 36 or SF-36 will be used, which measures domains such as functional capacity, physical aspects, pain, general health status, vitality, social aspects, emotional aspects and mental health. The scale ranges from 0 to 100 in each of the domains, with the highest values related to improvement.